Business Wire

Bona Germany Welcomes Emission-Free, Scania Electric Truck to Facility in Limburg

Share

Bona®, a global, sustainably-driven company that supplies products for installing, renovating, maintaining, and restoring premium floors, and Scania, one of the world's leading providers of transport solutions, hosted an event yesterday to welcome Bona’s first electric truck to its facility in Limburg, Germany. The Scania innovated truck is from the Scania P series and will offer an emission-free transport system for Bona’s operations in Limburg and the surrounding area. It is the first of its kind to be operated in Germany.

This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20211130005952/en/

To view this piece of content from mms.businesswire.com, please give your consent at the top of this page.

Bona and Scania hosted an event on November 30 to welcome Bona’s first electric truck to its facility in Limburg, Germany. Pictured from left to right: Christian Löher, Managing Director Bona Vertriebsgesellschaft mbH Deutschland / Regional Sales Manager Region Central; Dr. Thomas Brokamp, Managing Director, Bona GmbH Deutschland; Monika Sommer, Hauptgeschäftsführerin IHK Limburg / CEO of the Chamber of Commerce and Industry, Region Limburg / Weilburg; Jörg Sauer, Kreisbeigeordneter Landkreis Limburg Weilburg / District Councilor; Dr. Marius Hahn, Bürgermeister Limburg an der Lahn / Mayor; Christian Hottgenroth, Direktor Verkauf Lkw Scania Deutschland Österreich / Director of Sales Germany / Austria; Thorsten Kusch, Supply Chain Director for EMEA / APAC at DC 1, Bona (Photo: Business Wire)

"Bona is committed to incorporating and pursuing sustainable products, systems, and practices throughout the company and the new Scania electric truck is an important milestone in our journey to a greener future,” said Dr. Thomas Brokamp, Managing Director, Bona Germany. “Scania advised us well on the choice of our electric vehicle and gave us a good introduction to this new technology. The Scania electric truck is perfectly tailored to our needs and areas of operation.” The battery-electric truck will act as a city shuttle, making multiple trips a day to transport finished products from the production plant in the south of the city to the distribution center in the north, just under six kilometers away. Approximately 21 euro pallets can be accommodated in the loading area on each tour.

A POWERFUL DRIVE SYSTEM AND COMFORTABLE RIDE

The new model in the Scania P series, called the Scania 25 P, was specially designed for inner-city use and is characterized by comfortable access to the cab and excellent traffic visibility. The number in the model designation indicates the power that the truck travels, up to 230 kW (312 hp) rated engine power, which is enough power to move the three-axle truck's permissible weight of 26 tons with ease.

"The electric powertrain shines, especially at low engine speeds and in starting situations, with significantly better acceleration and more tractive power compared to a diesel truck," said Christian Hottgenroth, Director of Truck Sales, Scania Germany Austria. “In practice, drivers can therefore look forward to rapid acceleration and short response times from the drive.”

The Scania 25 P stores the energy for propulsion in five lithium-ion batteries, each with a capacity of 33 kW/h. "The electric range depends primarily on the factors of driving style, load, as well as topography," Hottgenroth explained further. Under optimal conditions, the drive batteries with the total capacity of 165 kW/h are designed for a range of up to 110 kilometers, while 70 to 90 kilometers can be expected in real driving conditions. For Bona’s use in the city of Limburg, which will average approximately 50 kilometers per day, the power is completely sufficient for the planned operating profile.

POWERED WITH SUSTAINABLE ENERGY

Because Bona’s Limburg facility is equipped with solar panels, the new Scania truck will be fueled by green electricity generated by a powerful photovoltaic system on the roof of the large hall. The fully electric truck is charged with direct current and is equipped with a charging capacity of 130 kW, which allows the batteries to be fully charged in about an hour at 20 percent capacity. If more range is required, a stop of half an hour at the charging station is enough to charge energy for another 50 or 60 kilometers.

“Moving to an emission-free vehicle is an important part of our broader sustainability journey and part of our commitment to be a good citizen. Due to high traffic the city of Limburg has a problem with excessively high nitrogen dioxide levels. The main source are diesel vehicles, and it is now extremely likely a ban for these vehicles is coming 1st of April 2022 for Limburg. With our emission-free truck we can make a valuable contribution in Limburg to lower nitrogen dioxide levels and to global decarbonization," said Dr. Brokamp. The fact that the electric truck from Scania also runs locally with zero emissions and is virtually noise-free due to its low-noise drive are also benefits of the all-electric truck.

Bona is in the process of finalizing the electric charging station, which is slated for completion by early 2022.

ABOUT BONA

Bona is a family-owned, sustainably-driven company that supplies products for installing, renovating, maintaining, and restoring premium floors. Founded in 1919, Bona was the first in the industry to offer a full system of waterborne hardwood floor finishing and floor care products. Today, Bona offers products for most premium floor surfaces including wood, tile, vinyl, resilient, rubber, and laminate. Bona’s turnover is 3.1bn SEK (EUR 307 million) 2020. The head office is in Malmö, Sweden, and the company is represented globally by its 17 subsidiaries, 70 distributors, 600 employees, and 5 factories. For more, visit www.bona.com.

To view this piece of content from cts.businesswire.com, please give your consent at the top of this page.

Contact information

Heather Lindemann | Bona
+1 (800) 872-5515
heather.lindemann@bona.com

Rüdiger Weil | Bona Germany
+49 6431 4008-134
Ruediger.Weil@bona.com

About Business Wire

For more than 50 years, Business Wire has been the global leader in press release distribution and regulatory disclosure.

Subscribe to releases from Business Wire

Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.

Latest releases from Business Wire

Ant International Wins Champion of NeurIPS Competition of Fairness in AI Face Detection8.12.2025 05:37:00 EET | Press release

Ant International, a leading global digital payment, digitisation, and financial technology provider, has won first place at the NeurIPS Competition of Fairness in AI Face Detection. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20251207210856/en/ Ant International’s solution takes top spot at the NeurIPS Competition of Fairness in AI Face Detection, emerging first among over 2,100 submissions from 162 teams globally. AI Fairness enhances Financial Security Studies by the National Institute of Standards and Technology (NIST) show that many commercial facial recognition algorithms have significantly higher error rates for women and people of colour largely due to underrepresentation in datasets AI algorithms are trained on. Biased algorithms lead to unfair denials of service and create security vulnerabilities. The competition at the Conference on Neural Information Processing Systems, among the world’s most prestigious AI con

Sonrotoclax Data at ASH 2025 Confirm Foundational Potential Across B-cell Malignancies8.12.2025 01:00:00 EET | Press release

BeOne Medicines Ltd. (Nasdaq: ONC; HKEX: 06160; SSE: 688235), a global oncology company, today announced new data on sonrotoclax, a next-generation investigational BCL2 inhibitor, demonstrating meaningful clinical benefit as monotherapy and in combination across B-cell malignancies. These data were featured at the 67th American Society of Hematology (ASH) Annual Meeting & Exposition in Orlando, Florida. The five presentations highlight durable responses in heavily pretreated patients with relapsed/refractory (R/R) mantle cell lymphoma (MCL) and additional studies showing deep, rapid, and sustained undetectable minimal residual disease (uMRD) rates with sonrotoclax-based combinations in patients with treatment-naive chronic lymphocytic leukemia (CLL), highlighting the foundational potential of this medicine. “The data we’re presenting at ASH 2025 are redefining what physicians can expect from sonrotoclax as a next-generation BCL2 inhibitor,” said Amit Agarwal, M.D., Ph.D., Chief Medical

Hemato-Oncology Trials: AOP Health Presents New Results at Top Congress ASH7.12.2025 18:00:00 EET | Press release

AOP Health continues to advance its clinical research program in myeloproliferative neoplasms, a special group of rare blood cancers. The company, specialized in rare diseases, presented the results of two scientific investigations at the 67th American Society of Hematology Association (ASH) Annual Meeting 2025 held in Orlando, FL, USA. The results provide new insights in treatment strategies. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20251207587915/en/ Dr. Martin Steinhart, CEO AOP Health; Photo credit: AOP Health/Studio Koekart ROP-ET and BESREMI PASS One of the clinical studies, ROP-ET, examined the use of ropeginterferon alfa-2b in people with essential thrombocythemia (ET), a disease in which the body produces too many platelets. The trial, a prospective, multicenter, single-arm phase III study, investigated the safety and efficacy of ropeginterferon alfa-2b in ET patients unable to receive available cytoreductive th

CoMotion GLOBAL 2025 Launches in Riyadh: Global Mobility Leaders Unite in Saudi Capital to Chart Urban Future7.12.2025 14:00:00 EET | Press release

Riyadh is rapidly becoming one of the world's most ambitious urban mobility laboratories, where next-generation technologies move from blueprint to real-world deployment on city streets at unprecedented scale. CoMotion GLOBAL 2025, the world's most influential gathering of urban mobility leaders, opens today in Riyadh for a three-day summit bringing together innovators from Africa, Asia, Europe, the Americas, and the Middle East. Running December 7-9, the event will explore how electrification, autonomy, AI-enabled transport, and giga-project urbanism are reshaping cities worldwide. The summit will spotlight everything from high-performance EVs and breakthrough autonomous fleets to emerging-market transport solutions and new mobility models, demonstrating how the Kingdom is opening new pathways for global mobility leadership. Strategic Partnerships Powering the Summit CoMotion GLOBAL 2025 is hosted by the Saudi Conventions & Exhibitions General Authority (SCEGA), supported by key Saudi

Deciphera Announces Oral Presentation of Positive Topline Results from Phase 2a Study of Sapablursen in Polycythemia Vera at the 67 th American Society of Hematology (ASH) Annual Meeting6.12.2025 16:30:00 EET | Press release

Deciphera Pharmaceuticals, a member of Ono Pharmaceutical Co., Ltd. (Headquarters: Osaka, Japan; President and COO: Toichi Takino; “Ono”), today announced the oral presentation of positive results from the Phase 2a IMPRSSION study of sapablursen in patients with polycythemia vera (PV) at the 67th American Society of Hematology (ASH) Annual Meeting, taking place December 6-9, 2025, in Orlando, FL. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20251206361611/en/ The results were presented by Ionis Pharmaceuticals, who discovered and developed sapablursen and conducted the IMPRSSION study. In March 2025, Ionis and Ono entered into a license agreement in which Ono obtained exclusive global rights for the development and commercialization of sapablursen. “In the treatment of PV, phlebotomy and cytoreductive therapy are performed as treatments for preventing thrombosis. Phlebotomy is the most common treatment for PV, in which blood

In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.

Visit our pressroom
World GlobeA line styled icon from Orion Icon Library.HiddenA line styled icon from Orion Icon Library.Eye